{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/GALT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-09T04:45:01.716Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":231,"canonical_name":"GALECTIN THERAPEUTICS INC","cik":"0001133416","uei":null,"lei":null,"duns":null,"ticker":"GALT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":28},"count":28,"timeline":[{"ts":"2026-07-16","kind":"sec.filing","form_type":"4","title":"4 — GALECTIN THERAPEUTICS INC — 2026-07-16","url_slug":"/sec/cik-0001133416/4/0001133416-26-000063","accession_number":"0001133416-26-000063","importance":30},{"ts":"2026-07-14","kind":"sec.insider.s","reporter":"Jamil Khurram","title":"Chief Medical Officer","shares":16250,"price_per_share":5.1252,"usd_value":83285,"security_title":"Common Stock","importance":35.0832845},{"ts":"2026-07-14","kind":"sec.insider.m","reporter":"Jamil Khurram","title":"Chief Medical Officer","shares":16250,"price_per_share":3.04,"usd_value":49400,"security_title":"Common Stock","importance":15.0494},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — GALECTIN THERAPEUTICS INC — 2026-06-30","url_slug":"/sec/cik-0001133416/4/0001133416-26-000059","accession_number":"0001133416-26-000059","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — GALECTIN THERAPEUTICS INC — 2026-06-30","url_slug":"/sec/cik-0001133416/4/0001133416-26-000061","accession_number":"0001133416-26-000061","importance":30},{"ts":"2026-06-29","kind":"sec.form144","reporter":"Harold Shlevin","title":"Director","shares":22268,"usd_value":112212,"security_title":"COMMON","approx_sale_date":"2026-06-29","accession_number":"0001628280-26-045997","importance":40.022442376},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Jamil Khurram","title":"Chief Medical Officer","shares":47467,"price_per_share":5.04,"usd_value":239234,"security_title":"Common Stock","importance":35.23923368},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Shlevin Harold H.","title":null,"shares":22268,"price_per_share":5.04,"usd_value":112231,"security_title":"Common Stock","importance":35.11223072},{"ts":"2026-06-29","kind":"sec.filing","form_type":"144","title":"144 — GALECTIN THERAPEUTICS INC — 2026-06-29","url_slug":"/sec/cik-0001133416/144/0001628280-26-045997","accession_number":"0001628280-26-045997","importance":30},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Jamil Khurram","title":"Chief Medical Officer","shares":47467,"price_per_share":2.5,"usd_value":118668,"security_title":"Common Stock","importance":15.1186675},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Shlevin Harold H.","title":null,"shares":22268,"price_per_share":1.23,"usd_value":27390,"security_title":"Common Stock","importance":15.02738964},{"ts":"2026-06-26","kind":"sec.form144","reporter":"Jamil Khurram","title":"Officer","shares":68287,"usd_value":341435,"security_title":"Common Stock","approx_sale_date":"2026-06-26","accession_number":"0001972481-26-000216","importance":40.068287},{"ts":"2026-06-26","kind":"sec.form144","reporter":"HAROLD SHLEVIN","title":"DIRECTOR","shares":7732,"usd_value":38680,"security_title":"COMMON","approx_sale_date":"2026-06-26","accession_number":"0001628280-26-045766","importance":40.007736},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Shlevin Harold H.","title":null,"shares":7732,"price_per_share":5,"usd_value":38660,"security_title":"Common Stock","importance":35.03866},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Jamil Khurram","title":"Chief Medical Officer","shares":2533,"price_per_share":5,"usd_value":12665,"security_title":"Common Stock","importance":35.012665},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Jamil Khurram","title":"Chief Medical Officer","shares":2037,"price_per_share":5,"usd_value":10185,"security_title":"Common Stock","importance":35.010185},{"ts":"2026-06-26","kind":"sec.filing","form_type":"144","title":"144 — GALECTIN THERAPEUTICS INC — 2026-06-26","url_slug":"/sec/cik-0001133416/144/0001628280-26-045766","accession_number":"0001628280-26-045766","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"144","title":"144 — GALECTIN THERAPEUTICS INC — 2026-06-26","url_slug":"/sec/cik-0001133416/144/0001972481-26-000216","accession_number":"0001972481-26-000216","importance":30},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Shlevin Harold H.","title":null,"shares":7732,"price_per_share":1.23,"usd_value":9510,"security_title":"Common Stock","importance":15.00951036},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Jamil Khurram","title":"Chief Medical Officer","shares":2533,"price_per_share":2.5,"usd_value":6333,"security_title":"Common Stock","importance":15.0063325},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Jamil Khurram","title":"Chief Medical Officer","shares":2037,"price_per_share":2.2,"usd_value":4481,"security_title":"Common Stock","importance":15.0044814},{"ts":"2026-06-23","kind":"sec.form144","reporter":"Jamil Khurram","title":"Officer","shares":8125,"usd_value":25500,"security_title":"Common Stock","approx_sale_date":"2026-06-23","accession_number":"0001972481-26-000208","importance":40.0051},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"Jamil Khurram","title":"Chief Medical Officer","shares":7557,"price_per_share":3.14,"usd_value":23729,"security_title":"Common Stock","importance":35.02372898},{"ts":"2026-06-23","kind":"sec.filing","form_type":"8-K","title":"8-K — GALECTIN THERAPEUTICS INC — 2026-06-23","url_slug":"/sec/cik-0001133416/8-k/0001140361-26-026031","accession_number":"0001140361-26-026031","importance":35},{"ts":"2026-06-23","kind":"sec.filing","form_type":"144","title":"144 — GALECTIN THERAPEUTICS INC — 2026-06-23","url_slug":"/sec/cik-0001133416/144/0001972481-26-000208","accession_number":"0001972481-26-000208","importance":30},{"ts":"2026-06-23","kind":"sec.insider.m","reporter":"Jamil Khurram","title":"Chief Medical Officer","shares":7557,"price_per_share":1.23,"usd_value":9295,"security_title":"Common Stock","importance":15.00929511},{"ts":"2026-05-15","kind":"sec.filing","form_type":"10-Q","title":"10-Q — GALECTIN THERAPEUTICS INC — 2026-05-15","url_slug":"/sec/cik-0001133416/10-q/0001140361-26-021495","accession_number":"0001140361-26-021495","importance":45},{"ts":"2026-05-15","kind":"sec.filing","form_type":"8-K","title":"8-K — GALECTIN THERAPEUTICS INC — 2026-05-15","url_slug":"/sec/cik-0001133416/8-k/0001140361-26-021496","accession_number":"0001140361-26-021496","importance":35}]}